Author Joe Dolce explains how psychedelics are moving from counterculture to mainstream, with new science, shifting laws, and surprising therapies that promise to change how we treat addiction, anxiety, and self-discovery.
The agency's puzzling concerns about the Lykos Therapeutics drug application
William Burroughs and Allen Ginsberg's trip reports form one of the most entertaining books in the Beat canon.
City Journal's Rafael Mangual and Charles Fain Lehman debate Reason's Billy Binion and Jacob Sullum on legalizing all drugs.
Drug Smuggler. Fugitive. Icon. Meet The Acid Queen.
A religious group using psilocybin mushrooms in ceremonies "put the State of Utah's commitment to religious freedom to the test," a federal judge wrote.
Plaintiffs’ argument that access to in-home psilocybin services for those with disabilities is required under the ADA survives motion to dismiss.
Authors James Fadiman and Jordan Gruber discuss their new book Microdosing for Health, Healing, and Enhanced Performance.
The ruling by U.S. District Judge Jill Parrish emphasizes that religious freedom must protect "unpopular or unfamiliar religious groups" as well as "popular or familiar ones."
Many people depicted in a supposedly "groundbreaking" book on psychedelics and religion are now speaking out against it.
Researchers gave psilocybin to two dozen religious clergy. Was it guided by science, religion, or some awkward combination?
Recent election results show the drug war’s punitive mentality still appeals to many Americans, even in blue states.
Pharmacological Perennialism crossed paths with the Catholic Church at a previously unreported "holy meeting."
Making DOI and DOC Schedule I drugs would interfere with psychiatric research.
Trippy author Ernesto Londoño points out that supposedly ancient psychedelic rituals don't always lead to great outcomes.
Despite a few bright spots, the disappointing returns suggest that the road to pharmacological freedom will be rockier than activists hoped.
The initiative also would have authorized state-licensed "psychedelic therapy centers."
The ballot initiatives would allow recreational marijuana use in Florida and the Dakotas, authorize medical marijuana in Nebraska, and decriminalize five natural psychedelics in Massachusetts.
This Kentucky Republican won't stop until he finds a state willing to make legal room for ibogaine, a drug he calls "God's medicine."
This Kentucky Republican won't stop until he finds a state willing to make legal room for ibogaine, a drug he calls "God's medicine."
An FDA advisory committee concluded that MDMA's benefits had not been shown to outweigh its risks.
The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical trial, which would take years and millions of dollars.
The agency claims DOI and DOC have "a high potential for abuse" because they resemble other drugs it has placed in Schedule I.
The now-dead bill would have permitted three counties to establish pilot programs in which military veterans could take psilocybin under the supervision of medical professionals.
The panel's recommendation, based on several concerns about two clinical trials, is a serious setback for a promising PTSD treatment.
The head of Students for Sensible Drug Policy clarifies the misconceptions around decriminalization, safe injection sites, and whether Trump or Biden is better on drug policy.
I asked artificial intelligence to tell me how to take psychedelic mushrooms.
The former Cheers producer talks faith, ayahuasca, and what it’ll take to bring back the blockbuster comedy.
Mind-altering drugs have long been seen as tools for both liberation and control.
The sequel is about ecology, politics, economics, imperialism, and much more. But mostly it's about worms.
In 2024, the FDA will decide whether or not MDMA can be used to treat patients suffering from PTSD.
Intoxicants might be a source of problems—or enhance our ability to cope.
Comedian Shane Mauss on the democratization of mushrooms, LSD, cannabis, DMT, and ketamine
The death of the Friends star should remind us of the costs of the war on drugs.
The psychedelic comedian talks cognitive liberty and the mind-blowing pace of legalization efforts.
Newsom vetoed both reforms, which he deemed excessively permissive.
Historian Erika Dyck contextualizes the deep roots of and battles over LSD, psilocybin, and other psychoactive substances.
The former Texas governor spoke with Reason's Nick Gillespie at the Psychedelic Science 2023 conference in Denver.
The former Texas governor on helping veterans with PTSD, increasing legal immigration, and the illegal drug he'd most like to try
Historian Erika Dyck wants to document the deep roots of and battles over LSD, psilocybin, and other psychoactive substances.
Plus: The Biden administration weighs a "remain in Texas" policy, California slowly but surely reforms its housing-killing environmental review law, and more...
The founder of MAPS talks about FDA approval for MDMA-assisted therapy and the "psychedelic renaissance" he has helped create.
The Colorado governor finds common ground with many libertarians. But does he really stand for more freedom?
Reason's Nick Gillespie talked with Mauss, a comedian who tours the country discussing his psychedelic experiences, at the Psychedelic Science 2023 conference.
The former Texas governor on helping veterans with PTSD, increasing legal immigration, and the illegal drug he'd most like to try
Reason's Nick Gillespie talked with MAPS founder Rick Doblin about the imminent FDA approval of MDMA- and psilocybin-assisted therapy at the Psychedelic Science conference in Denver.
"I can tell you none of us were affected by the mushrooms," Yellen insisted to CNN.
